Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
1359 | 2 | EPOTHILONES//PACLITAXEL//COMBRETASTATIN | 8558 |
5851 | 1 | COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS | 1594 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | COMBRETASTATIN | authKW | 2430762 | 9% | 87% | 142 |
2 | COMBRETASTATIN A 4 | authKW | 1746528 | 8% | 74% | 120 |
3 | VASCULAR DISRUPTING AGENTS | authKW | 1304873 | 7% | 61% | 109 |
4 | PHENSTATIN | authKW | 415179 | 1% | 100% | 21 |
5 | TUBULIN POLYMERIZATION | authKW | 407825 | 4% | 37% | 56 |
6 | SCREENING TECHNOL BRANCH | address | 398564 | 4% | 29% | 70 |
7 | CANC TREATMENT DIAGFREDERICK CANC | address | 381955 | 2% | 60% | 32 |
8 | COMBRETASTATIN A4 PHOSPHATE | authKW | 373512 | 1% | 82% | 23 |
9 | ZD6126 | authKW | 371231 | 2% | 72% | 26 |
10 | TUBULIN POLYMERIZATION INHIBITORS | authKW | 365348 | 2% | 60% | 31 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 34014 | 43% | 0% | 687 |
2 | Oncology | 3860 | 27% | 0% | 426 |
3 | Chemistry, Organic | 2761 | 20% | 0% | 315 |
4 | Pharmacology & Pharmacy | 1446 | 19% | 0% | 310 |
5 | Biochemistry & Molecular Biology | 327 | 16% | 0% | 256 |
6 | Chemistry, Multidisciplinary | 91 | 8% | 0% | 129 |
7 | Radiology, Nuclear Medicine & Medical Imaging | 39 | 3% | 0% | 52 |
8 | Biochemical Research Methods | 5 | 2% | 0% | 26 |
9 | Cell Biology | 5 | 3% | 0% | 51 |
10 | Crystallography | 2 | 1% | 0% | 16 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SCREENING TECHNOL BRANCH | 398564 | 4% | 29% | 70 |
2 | CANC TREATMENT DIAGFREDERICK CANC | 381955 | 2% | 60% | 32 |
3 | DEV THER EUT PROGRAMNIH | 227810 | 1% | 52% | 22 |
4 | CANC TREATMENT DIAGNIH | 216474 | 2% | 30% | 37 |
5 | ONCOEMATOL | 129741 | 1% | 35% | 19 |
6 | UNITA ONCOL SPERIMENTALE IMMUNOL | 98852 | 0% | 100% | 5 |
7 | LP4 | 82375 | 0% | 83% | 5 |
8 | DIPARTIMENTO SALUTE DONNA BAMBINO | 69483 | 1% | 23% | 15 |
9 | GRAY CANC | 69228 | 2% | 12% | 29 |
10 | TUMOR MICROCIRCULAT GRP | 68334 | 1% | 31% | 11 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY | 19387 | 7% | 1% | 115 |
2 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 18103 | 6% | 1% | 95 |
3 | JOURNAL OF MEDICINAL CHEMISTRY | 17412 | 9% | 1% | 139 |
4 | MEDCHEMCOMM | 8205 | 2% | 2% | 25 |
5 | CHEMMEDCHEM | 7819 | 2% | 1% | 31 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 5564 | 5% | 0% | 86 |
7 | INVESTIGATIONAL NEW DRUGS | 4351 | 2% | 1% | 24 |
8 | ANTI-CANCER DRUG DESIGN | 2536 | 1% | 1% | 9 |
9 | CHEMICAL BIOLOGY & DRUG DESIGN | 2489 | 1% | 1% | 15 |
10 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 2009 | 1% | 1% | 11 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COMBRETASTATIN | 2430762 | 9% | 87% | 142 | Search COMBRETASTATIN | Search COMBRETASTATIN |
2 | COMBRETASTATIN A 4 | 1746528 | 8% | 74% | 120 | Search COMBRETASTATIN+A+4 | Search COMBRETASTATIN+A+4 |
3 | VASCULAR DISRUPTING AGENTS | 1304873 | 7% | 61% | 109 | Search VASCULAR+DISRUPTING+AGENTS | Search VASCULAR+DISRUPTING+AGENTS |
4 | PHENSTATIN | 415179 | 1% | 100% | 21 | Search PHENSTATIN | Search PHENSTATIN |
5 | TUBULIN POLYMERIZATION | 407825 | 4% | 37% | 56 | Search TUBULIN+POLYMERIZATION | Search TUBULIN+POLYMERIZATION |
6 | COMBRETASTATIN A4 PHOSPHATE | 373512 | 1% | 82% | 23 | Search COMBRETASTATIN+A4+PHOSPHATE | Search COMBRETASTATIN+A4+PHOSPHATE |
7 | ZD6126 | 371231 | 2% | 72% | 26 | Search ZD6126 | Search ZD6126 |
8 | TUBULIN POLYMERIZATION INHIBITORS | 365348 | 2% | 60% | 31 | Search TUBULIN+POLYMERIZATION+INHIBITORS | Search TUBULIN+POLYMERIZATION+INHIBITORS |
9 | COLCHICINE BINDING SITE | 320278 | 1% | 90% | 18 | Search COLCHICINE+BINDING+SITE | Search COLCHICINE+BINDING+SITE |
10 | TUBULIN | 301579 | 12% | 8% | 184 | Search TUBULIN | Search TUBULIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |